
ProPhase Labs (PRPH) Earnings Dates & Reports
ProPhase Labs (PRPH) Most Recent Earnings
Report Date
Period EndingQ3 2025
Est. EPS-$0.11
Actual EPS-$0.16
EarningsMiss
ProPhase Labs (PRPH) Earnings
View the latest ProPhase Labs (PRPH) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in ProPhase Labs (PRPH)
Order type
Buy in
Order amount
Est. shares
0 shares
ProPhase Labs (PRPH) Earnings per Share (EPS) History
Signup for full accessBrowse free
ProPhase Labs (PRPH) Latest Earnings
The value each PRPH share was expected to gain vs. the value each share gained.
ProPhase Labs (PRPH) reported its most recent earnings on for Q3 2025, posting earnings per share (EPS) of -$0.16. This exceeded analysts' expectations of -$0.11 by 45.45%, marking a Miss.
For comparison, ProPhase Labs reported EPS of -$0.35 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.12.
ProPhase Labs (PRPH) Earnings History
ProPhase Labs (PRPH) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the ProPhase Labs’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
ProPhase Labs (PRPH) Earnings FAQs
ProPhase Labs (PRPH) last reported earnings on Nov 19, 2025 for Q3 2025, posting an EPS of -$0.16, which Miss the estimate of -$0.11 by 45.45%.
For Q3 2025, ProPhase Labs (PRPH) reported an EPS of -$0.16, missing analysts' estimate of -$0.11 by 45.45%.
For Q3 2025, ProPhase Labs (PRPH) Miss expectations with an actual EPS of -$0.16 vs. an estimated EPS of -$0.11.
Following the last earnings report on Nov 19, 2025, ProPhase Labs (PRPH)'s stock price moved — from — to —.
The next ProPhase Labs (PRPH) earnings call is scheduled for Mar. 30, 2026, where executives will discuss financial results and outlook.